PRNewswire/ -- Isofol Medical AB's (publ) (Nasdaq First North Premier Growth Market: ISOFOL) ("Isofol" or the "Company") Board of Directors have today, pursuant to the authorization granted by the ... ( read original story ...)
China Market Update: Bargain Hunters Lift Hong Kong
Alibaba HK (9988 HK) was the most heavily traded stock today off -0.63% as short selling increased on speculation that US-listed shares were being converted to Hong Kong shares to be sold. ( read original story ...)
Lotte chief likely to push for Hotel Lotte IPO to win power struggle
Lotte Group Chairman Shin Dong-bin is likely to accelerate the initial public offering of its key subsidiary Hotel Lotte to consolidate his grip on the multinational group’s South Korean entities amid ... ( read original story ...)
Tokio Marine to use Tractable’s AI to analyse auto damage across Japan
Tokio Marine, one of the world's largest property and casualty insurers*, is to use an AI solution to process auto damage across its ... ( read original story ...)
How lax rules, missed warnings led to Japan’s 2nd virus cruise ship hot spot
Seven days before Japan quarantined a cruise ship in Yokohama early this year, in what became one of the first coronavirus hot spots outside China, another cruise ship docked in southern Japan. For ... ( read original story ...)
Why Your Crypto Exchange Tax Documents Might Not Be Accurate
All major exchanges face a tax reporting challenge stemming from one of cryptocurrency’s core features: transferability. ( read original story ...)
SoftBank writes down WeWork by $6.6 billion, compounding portfolio misery
SoftBank Group Corp said it sees a loss of around 700 billion yen ($6.6 billion) in the year ending March on the portion of its WeWork investment held outside the Vision Fund, as the virus compounds ... ( read original story ...)
SoftBank Expects Up To $6.6B Loss From WeWork Over The Past Year
On the portion of its WeWork investment held outside its Vision Fund, SoftBank said it expects a loss of what works out to be $6.6B for the year ending March, Reuters reports . “Every writedown takes ... ( read original story ...)
News Corp Australia Partners with Flybuys; US Local Media Advertising Down 3.6%
News Corp Australia partners with customer loyalty platform Flybuys to bolster its audience segments; US local media advertising is expected to fall by 3.6% as Coronavirus keeps live sports on hold; ... ( read original story ...)
Other Media | SalmonBusiness: Salmones Austral gets IPO approval, but can’t list until COVID 19 calms down
Chilean salmon farmer plans to list on the Santiago Stock Exchange. Aqua.cl reports that Salmones Austral has been given the nod from the Financial Market Commission (CMF) to register its company and ... ( read original story ...)
Naotsune Alliance to Open a New Office Location in Hong Kong
Naotsune Alliance, a financial advisor for the world of business that provides discretionary investment advisory services for individual clients, wealthy families, institutional investors and ... ( read original story ...)
Japan approves Gilead Sciences’ remdesivir as COVID-19 drug
Japan has approved Gilead Sciences Inc's remdesivir as a treatment for COVID-19, the health ministry said on Thursday, making it the country's first officially authorised drug for the disease. ( read original story ...)
Osaka governor draws rebuke from Tokyo for hinting at lack of guidance
Gov. Yoshimura’s choice of words has been criticized by minister Yasutoshi Nishimura, who is also in charge of overseeing virus containment measures. ( read original story ...)
Coronavirus-wary Japan tries to take business card ritual online
Japan's time-honoured ritual of exchanging business cards face-to-face is under pressure as the government promotes a "new lifestyle" to combat the coronavirus. ( read original story ...)
Three US Marines subdue disruptive passenger on Japan-to-Texas flight: report
Three fast-responding U.S. Marines are being credited with subduing a disruptive passenger Monday during a flight from Tokyo to Dallas. ( read original story ...)
Japan Biopharma Venture Has Surged Almost 400% on Vaccine Hopes
A Japanese biopharma venture has surged almost 400% in just over two months on hopes that its vaccine candidate for the coronavirus will be successful.AnGes Inc., a spin-off from Osaka University, ... ( read original story ...)